Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
Brian J PotterGiuseppe AndòGiovanni CimminoRicardo Ladeiras-LopesZied FrikahXin Yue ChenVittorio VirgaJoao Goncalves-AlmeidaA John CammKeith A A FoxPublished in: Clinical cardiology (2018)
Despite little change over time in clinical characteristics of AF patients undergoing PCI, significantly more patients received OAC at presentation. However, triple therapy was not more frequent in the Recent cohort, and ACS presentation was associated with lack of OAC at discharge. We underscore the need for trial evidence and use of updated guidelines to assist clinicians in balancing ischemic and bleeding risks.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- patients undergoing
- left atrial
- catheter ablation
- newly diagnosed
- coronary artery disease
- direct oral anticoagulants
- left atrial appendage
- percutaneous coronary intervention
- acute coronary syndrome
- end stage renal disease
- ejection fraction
- heart failure
- coronary artery
- case report
- clinical trial
- palliative care
- prognostic factors
- stem cells
- antiplatelet therapy
- ischemia reperfusion injury
- aortic stenosis
- bone marrow
- phase iii
- randomized controlled trial
- st segment elevation myocardial infarction
- open label
- climate change
- double blind
- left ventricular
- patient reported
- transcatheter aortic valve replacement
- brain injury
- mitral valve